Midbrain dopaminergic neuronal degeneration m a transgenic mouse model of familial amyotrophic lateral sclerosis

Annals of Neurology

Volumn 41, Issue 4, 1997, Pages 497-504

  Kostic, V ^a   Gurney, M E ^b   Deng, H X ^c   Siddique, T ^b,c   Epstein, C J ^d   Przedborski, S ^a,e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; MALE; MESENCEPHALON; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; SPINAL CORD MOTONEURON; SUBSTANTIA NIGRA; TRANSGENIC MOUSE; VENTRAL TEGMENTUM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; MICE; MICE, TRANSGENIC; SUPEROXIDE DISMUTASE; WALLERIAN DEGENERATION;

EID: 0030887622     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410413     Document Type: Article

References (35)

1. Rowland LP. Amyotrophic lateral sclerosis: human challenge for neuroscience. Proc Natl Acad Sci USA 1995;92:1251-1253
2. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62
3. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science 1993;261:1047-1051
4. Pardo CA, Xu Z, Borchelt DR, et al. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 1995;92:954-958
5. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992;32: 804-812
6. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn Superoxide dismutase mutation. Science 1994;264:1772-1775
7. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-157
8. Bandmann O, Davis MB, Marsden CD, Harding AE. Sequence of the Superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:90-91
9. Saggu H, Cooksey J, Dexter D, et al. A selective increase in particulate Superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989;53:692-697
10. Martilla RJ, Lorentz H, Rinne UK. Oxygen toxicity protecting enzymes in Parkinson's disease: increase of Superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 1988;86:321-331
11. Epstein CJ, Avraham KB, Lovett M, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA 1987;84:8044-8048
12. Przedborski S, Kostic V, Jackson-Lewis V, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-l ,2,3,6-tetrahydropyridineinduced neurotoxicity. J Neurosci 1992;12:1658-1667
13. Przedborski S, Donaldson D, Jakowec M, et al. Brain superoxide dismutase, catalase and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann Neurol 1996;39:158-165
14. Przedborski S, Jackson-Lewis V, Yokoyama R, et al. Role of neuronal nitric oxide in MPTP (l-methyl-4-phenyl-1,2,3,6tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 1996;93:4565-4571
15. Sidman RL, Angevine JB Jr, Pierce ET. Atlas of the mouse brain and spinal cord. Cambridge, MA: Harvard University Press, 1971
16. Coggeshall RE, Lekan HA. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 1996;364:6-15
17. Chiu AY, Zhai P, Dal Canto MC, et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 1995;6:349-362
18. Przedborski S, Levivier M, Jiang H, et al. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 1995;67:631-647
19. Hagg T, Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc Natl Acad Sci USA 1993;90;6315-6319
20. Sauer H, Fischer W, Nikkhah G, et al. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res 1993;626:37-44
21. Baker H, Joh TH, Reis DJ. Genetic control of number of midbrain dopaminergic neurons in inbred strains of mice: relationship to size and neuronal density of the striatum. Proc Natl Acad Sci USA 1980;77:4369-4373
22. Jackson-Lewis V, Kostic V, Przedborski S. Developmental neuronal death in the substantia nigra pars compacta of the mouse. Soc Neurosci Abstr 1996;22:41
23. Rabizadeh S, Gralla EB, Borchelt DR, et al. Mutations associated with amyotrophic lateral sclerosis convert Superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 1995;92:3024-3028
24. Mendell JR, Chase TN, Engel W. Amyotrophic lateral sclerosis: metabolism of central monoamines and treatment with L-DOPA. Trans Am Neurol Assoc 1971;96:284-286 25.
25. Groner Y, Elroy-Stein O, Avraham KB, et al. Cell damage by excess of CuZnSOD and Down's syndrome, Biomed Pharmacother 1994;48:231-240
26. Beal MF, Ferrante RJ, Henshaw R, et al. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc Superoxide dismutase transgenic mice, J Neurochem 1995;65:919-922
27. Przedborski S, Khan U, Kostic V, et al. Increased Superoxide dismutase activity improves survival of cultured postnatal midbrain neurons. J Neurochem 1996;67:1383-1392
28. Reaume AG, Elliott JL, HofTman EK, et al. Motor neurons in Cu/Zn Superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996;13:43-47
29. Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-518
30. Wolf HK, Grain BJ, Siddique T. Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis. Clin Neuropathol 1991;6:291-296
31. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusion in the anterior horn cells. Arch Neurol 1967;16:232-243
32. Tanaka J, Nakamura H, Tabuchi Y, Takahashi K. Familial amyotrophic lateral sclerosis: features of multisystem degeneration. Acta Neuropathol (Berl) 1984;64:22-29
33. Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993;19:300-304
34. Przedborski S, Dhawan V, Donaldson D, et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc-superoxide dismutase mutations. Neurology 1996 (in press)
35. Hayashi H, Kato S, Kawada A. Amyotrophic lateral sclerosis patients living beyond respiratory failure. J Neurol Sci 1991;105:73-78